Gilead Sciences, Inc. Company Information
Gilead Sciences, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Gilead Sciences, Inc.
- Ticker: GIS
- Exchange: XTRA
- Founded: 1987
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$181.827b
- Listing Market Cap: €156.335b
- Shares Outstanding: 1.24b
- Website: https://www.gilead.com
Number of Employees
Location
- Gilead Sciences, Inc.
- 333 Lakeside Drive
- Foster City
- California
- 94404
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GILD | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jan 1992 |
| GIS | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Jan 1992 |
| GILD * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 1992 |
| GIS | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1992 |
| GILD | SNSE (Santiago Stock Exchange) | Yes | Common Stock | CL | USD | Jan 1992 |
| GILD | SWX (SIX Swiss Exchange) | Yes | Common Stock | CH | CHF | Jan 1992 |
| 0QYQ | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Jan 1992 |
| 1GILD | BIT (Borsa Italiana) | Yes | Common Stock | IT | EUR | Jan 1992 |
| GILD | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jan 1992 |
| GILDUS | BVL (Bolsa de Valores de Lima) | Yes | Common Stock | PE | USD | Jan 1992 |
| GILDCL | SNSE (Santiago Stock Exchange) | Yes | Common Stock | CL | CLP | Jan 1992 |
| GISD | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Stock | GB | EUR | Jan 1992 |
| GILD34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 2 REP 1 COM | BR | BRL | Apr 2016 | |
| GILD | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 4 REP 1 COM USD0.001 | AR | ARS | Apr 2019 | |
| GILDD | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 4 REP 1 COM USD0.001 | AR | USD | Apr 2019 | |
| GIS0 | DB (Deutsche Boerse AG) | CDR CIBC CAD HEDGED REG S | DE | EUR | Apr 2025 | |
| GILD | TSX (The Toronto Stock Exchange) | CDR CIBC CAD HEDGED REG S | CA | CAD | Apr 2025 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/09 16:50 |
| End of Day Share Price | 2026/09/09 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Gilead Sciences, Inc. is covered by 63 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Brian Skorney | Baird |
| James Birchenough | Barclays |